Pacific Biosciences of California, Inc.
PACB Real Time Price USDRecent trades of PACB by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PACB's directors and management
Government lobbying spending instances
-
$60,000 Oct 20, 2022 Issue: Health Issues
-
$60,000 Oct 19, 2022 Issue: Health Issues
-
$60,000 Jul 20, 2022 Issue: Health Issues
-
$60,000 Jul 19, 2022 Issue: Health Issues
-
$60,000 Apr 20, 2022 Issue: Health Issues
-
$50,000 Apr 19, 2022 Issue: Health Issues
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$50,000 Jan 19, 2022 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$20,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$20,000 Jul 20, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
PACB Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to PACB
Recent picks made for PACB stock on CNBC
ETFs with the largest estimated holdings in PACB
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $PACB stock a Buy, Sell, or Hold?
- What is the price target for $PACB stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $PACB stock?
- Who owns the most shares of $PACB stock?
- What funds own $PACB stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PACB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.